期刊文献+

两性霉素B聚氰基丙烯酸正丁酯纳米粒的制备及小鼠体内分布研究 被引量:6

Preparation of amphotericin B-polybutylcyanoacrylate-loaded nanoparticles and its distribution in mice
下载PDF
导出
摘要 目的:制备携载两性霉素的聚氰基丙烯酸正丁酯纳米粒(AmB-PBCA-NP),研究其对血脑屏障的透过能力。方法:孵化法制备AmB-PBCA-NP,以聚山梨酯-80进行表面修饰,建立高效液相色谱分析法,流动相选择乙腈-水(40:60)及4%乙酸,405 nm处检测。小鼠分3组,每组28只,分别注射AmB粉针剂、脂质体(AmB-L)及纳米制剂(AmB-PBCA-NP),通过检测小鼠脑组织等脏器中的药物浓度,评价其主动脑靶向作用。结果:AmB-PBCA-NP平均粒径94.38 nm,平均包封率为82%,载药量56.1%。给药后AmB粉针剂组小鼠脑内未能检测出药物,AmB-L组于3 h后测得微量浓度,而AmB-PBCA-NP组小鼠30 min即测得可观浓度,3 h后达133 ng/g。结论:聚山梨酯-80修饰的AmB-PBCA-NP具有主动脑靶向作用。 Objective: To prepare amphotericin B-polybutylcyanoacrylate-loaded nanoparticle (AmB-PBCA-NP) and to assess their ability to pass the blood-brain barrier. Methods.- AmB-PBCA-NP was prepared by incubation, with the surface modified by polysorbate 80. High-performance liquid chromatography (HPLC) method was established using acetonitrile and water (40 : 60, 4% of acetic acid) as mobile phase; detection was done at 405 nm. Mice were divided into 3 groups: AmB- injected, AmB-lipid-injected, and AmB-PBCA-NP-injected group. Brain-targeting ability of AmB-PBCA-NP was then evaluated by determination of AmB concentrations in mice brain and other specimens. Results: The mean diameter of the prepared AmB- PBCA-NP was 94.38 nm; the mean entrapment efficiency of the particles was 82% ; and the drug loading rate was 56.10%. It was found that AmB alone failed to pass the blood-brain barrier; only very low level of AmB was detected in AmB-lipid group 3 h after injection; moderate concentration of Amb was detected 30 min after injection of AmB-PBCA-NP and the concentration peaked at 133 ng/g 3 h after injection. Conclusion: AmB-PBCA-NP modified by polysorbate 80 can pass the blood-brain barrier .
出处 《第二军医大学学报》 CAS CSCD 北大核心 2007年第3期242-245,共4页 Academic Journal of Second Military Medical University
基金 上海市科委纳米专项基金(0452nm016).~~
关键词 脑膜炎 隐球菌性 两性霉素B 聚氰基丙烯酸正丁酯 血脑屏障 meningitis,cryptococcal amphotericin B polybutylcyanoacrylate blood-brain barrier
  • 相关文献

参考文献7

  • 1Gallis H A,Drew R H,Pickard W W.Amphotericin B:30 years of clinical experience.Rev Infect Dis[J].1990,12:308-329.
  • 2Schroder U,Sommerfeld P,Ulrich S,et al.Nanoparticle technology for delivery of drugs across the blood-brain barrier[J].J Pharm Sci,1998,87:1305-1307.
  • 3Lockman P R,Mumper R J,Khan M A,et al.Nanoparticle technology for drug delivery across the blood-brain barrier[J].Drug Dev Ind Pharm,2002,28:1-13
  • 4Goppert T M,Muller R H.Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain:comparison of plasma protein adsorption patterns[J].J Drug Target,2005,13:179-187.
  • 5Alyautdin R N,Petrov V E,Langer K,et al.Delivery of loperamide across the blood-brain barrier with polysorbate-80 coated polybutylanoacrylate nanoparticles[J].Pharm Res,1997,14:325-328.
  • 6Gulyaev A E,Gelperina S E,Skidn I N,et al.Significant transport of doxorubicin into the brain with polysorbate-80 coated nanoparticles[J].Pharm Res,1999,16:1564-1569.
  • 7徐楠,邹豪,温海,陈江汉.携载两性霉素B的聚氰基丙烯酸正丁酯纳米粒的制备及特性评价[J].第二军医大学学报,2006,27(10):1127-1130. 被引量:2

二级参考文献8

  • 1Gallis HA,Drew RH,Pickard WW.Amphotericin B:30 years of clinical experience[J].Rev Infect Dis,1990,12:308-329.
  • 2Alyautdin RN,Petrov VE,Langer K,et al.Delivery of loperamide across the blood-brain barrier with polysorbate-80 coated polybutylanoacrylate nanoparticles[J].Pharm Res,1997,14:325-328.
  • 3Ambruosi A,Yamamoto H,Kreuter J.Body distribution of polysorbate-80 and doxorubicin-loaded[14C]poly(butyl cyanoacrylate) nanoparticles after i.v.administration in rats[J].J Drug Target,2005,13:535-542.
  • 4Kreuter J,Alyautdin RN,Kharkevich DA,et al.Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)[J].Brain Res,1995,674:171-174.
  • 5Lockman PR,Mumper RJ,Khan MA,et al.Nanoparticle technology for drug delivery across the blood-brain barrier[J].Drug Dev Ind Pharm,2002,28:1-13.
  • 6Goppert TM,Muller RH.Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain:comparison of plasma protein adsorption patterns[J].J Drug Target,2005,13:179-187.
  • 7Ambruosi A,Khalansky AS,Yamamoto H,et al.Biodistribution of polysorbate 80-coated doxorubicin-loaded[14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats[J].J Drug Target,2006,14:97-105.
  • 8Shi N,Zhang Y,Zhu C,et al.Brain-specific expression of an exogenous gene after i.v.administration[J].Proc Natl Acad Sci USA,2001,98:12754-12759.

共引文献1

同被引文献121

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部